Close
In today’s complex clinical trial landscape, a reactive approach to supply chain planning is no longer viable. Intrigence transforms traditional planning through its AI-powered Supply Chain Strategy Development service, delivering intelligent, proactive solutions that significantly enhance your clinical trial readiness.
Our platform utilizes advanced algorithms and real-time data analytics to simulate multiple supply-demand scenarios, accounting for patient enrollment rates, regional regulations, and investigational product availability. This predictive capability allows us to create dynamic and adaptive supply strategies that not only reduce risk and waste but also ensure product availability across global sites.
Analyze patient enrollment trends and site readiness to forecast future needs.
Run "what-if" analyses to plan for contingencies and optimize supply flows.
Identify vulnerabilities early and develop data-backed mitigation strategies.
Rate and select the most reliable suppliers and logistics partners.
Intrigence continuously integrates trial milestones and protocol updates to automatically adjust your supply strategy in real time. It identifies potential bottlenecks early, recommends alternate sourcing or logistics routes, and evaluates supplier reliability and depot performance. This allows study teams to remain agile in a constantly shifting environment.
With Intrigence, sponsors and CROs gain access to visual dashboards, scenario-based modeling, and real-time alerts that help drive faster and smarter decisions. The result is a well-orchestrated supply plan that is lean, responsive, and aligned with study goals.
Our AI-powered approach not only accelerates trial startup but also mitigates the risk of costly delays due to supply gaps or overstocking. Whether you’re planning a single-country Phase II study or a complex, multi-national Phase III trial, Intrigence delivers the intelligence you need to execute with confidence.
